New Immunotherapy Offers Hope for Millions Suffering from Hay Fever and Allergic Rhinitis
Summary
A new sublingual immunotherapy method offers hope for millions suffering from hay fever and allergic rhinitis by providing long-term relief and potentially preventing asthma.
Key Points
- Over 400 million people worldwide suffer from allergic rhinitis, commonly known as hay fever.
- Sublingual immunotherapy, placing medicine under the tongue, is a safe and effective treatment that desensitizes the body to allergens.
- This treatment can provide long-term relief and reduce the risk of developing asthma, especially in children.
- Despite availability, many patients do not receive timely or adequate treatment due to lack of awareness and healthcare referral practices.
